New Key Statistics Module, Z-Score and F-Score
OTCPK:CHGCY Key Ratios
Market Cap $ M | 73,850.71 |
Enterprise Value $ M | 68,601.82 |
P/E(ttm) | 28.62 |
PE Ratio without NRI | 28.62 |
Forward PE Ratio | 28.81 |
Price/Book | 6.32 |
Price/Sales | 9.75 |
Price/Free Cash Flow | 31.93 |
Price/Owner Earnings | 49.48 |
Payout Ratio % | 0.35 |
Revenue (TTM) $ M | 7,692.00 |
EPS (TTM) $ | 0.79 |
Beneish M-Score | -2.31 |
10-y EBITDA Growth Rate % | 25.20 |
5-y EBITDA Growth Rate % | 31.70 |
y-y EBITDA Growth Rate % | 6.50 |
EV-to-EBIT | 18.95 |
EV-to-EBITDA | 18.95 |
PEG | 0.90 |
Shares Outstanding M | 3,291.03 |
Net Margin (%) | 33.87 |
Operating Margin % | 47.29 |
Pre-tax Margin (%) | 47.29 |
Quick Ratio | 4.17 |
Current Ratio | 5.09 |
ROA % (ttm) | 20.28 |
ROE % (ttm) | 23.98 |
ROIC % (ttm) | 36.97 |
Dividend Yield % | 1.22 |
Altman Z-Score | 23.54 |
CHGCY Number of Guru Trades
CHGCY Volume of Guru Trades
Gurus Latest Trades with OTCPK:CHGCY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CHGCY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Chugai Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:CHGCY
Total 0- 1